+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost



Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost



International Journal of Radiation Oncology, Biology, Physics 79(4): 1048-1054



The present study was performed to compare outcomes after breast conservation treatment with iridium-192 implant boost vs. electron boost. From 1977 to 1983, 141 patients were treated with whole breast radiotherapy followed by iridium-192 boost after breast-conserving surgery. They were matched 1:1 to patients treated with electron boost. Outcome measures included survival, local recurrence, cosmesis, and complications. Median follow-up was 16.7 and 12.6 years for the implant vs. electron groups (p < 0.001). Rates of local recurrence, freedom from distant metastases, and overall survival at 10/20 years did not differ between the groups, nor did patterns of first failure. Patients in the electron group were more likely to have excellent/good cosmesis than those in the implant group 1 year after radiotherapy (p = 0.014); this trend continued through 10 years but did not reach statistical significance at years 5/10. Complication rates were similar, although patients receiving electron boost seemed less likely to develop breast fibrosis than did those receiving implant boost (23/141 vs. 58/141, respectively, incidence rate ratio 0.7, p = 0.17). Twenty-year data demonstrate no difference in rates of local recurrence, freedom from distant metastases, overall survival, or patterns of failure between groups treated with these two well-described radiotherapy boost techniques. Better cosmesis was observed in the electron group 1 year after radiotherapy, with a trend continuing for 10 years. The incidence of complications was similar between the groups, with a trend toward increased fibrosis in patients receiving implant boost.

(PDF emailed within 0-6 h: $19.90)

Accession: 054162362

Download citation: RISBibTeXText

PMID: 20510548

DOI: 10.1016/j.ijrobp.2009.12.026


Related references

Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial. Annals of Oncology 23(10): 2591-2598, 2013

Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer. Breast Cancer Research and Treatment 170(1): 45-53, 2018

Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106(5): 991-999, 2006

Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. Journal of Clinical Oncology 26(3): 386-391, 2008

Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting. Breast Journal 12(2): 138-144, 2006

Long-Term Outcomes of Breast Conservation Therapy in Unifocal versus Multifocal Early Stage Breast Cancer Patients. International Journal of Radiation Oncology*biology*physics 99(2): E24-E25, 2017

The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial. Breast Cancer Research and Treatment 139(1): 115-123, 2013

The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. International Journal of Radiation Oncology, Biology, Physics 70(5): 1453-1459, 2007

Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma. International Journal of Radiation Oncology, Biology, Physics 73(5): 1475-1481, 2008

The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology. Breast Journal 15(6): 571-578, 2010

Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clinical Breast Cancer 9(2): 96-100, 2009

Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. International Journal of Radiation Oncology, Biology, Physics 75(5): 1304-1308, 2009

Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. Breast Diseases: A Year Book Quarterly 21(2): 154-155, 2010

Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer. Neoplasma 54(5): 413-423, 2007

Long-term Outcomes and Clinicopathologic Differences of African-American Versus White Patients Treated With Breast Conservation Therapy for Early-stage Breast Cancer. Breast Diseases: A Year Book Quarterly 20(2): 146-147, 2009